| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |